Michael Way on Open Access and Read & Publish in Journal of Cell Science
Editor-in-Chief, Michael Way, talks about Journal of Cell Science, the importance of Open Access publishing and how The Company of Biologists’ Read & Publish initiative benefits researchers.
Transcript
Michael Way: Hello, my name is Michael Way, I am the Editor-in-Chief of Journal of Cell Science published by The Company of Biologists.
Michael Way: We are a journal that publishes cutting-edge work on cell biology and to give you an idea what that really means, the cell is the unit of life, we are all made of cells, cells interact with each other and their environment.We want to understand how cells function so we can understand how we work and how things go wrong.
Michael Way: So at Journal of Cell Science, we are always looking for cutting-edge research that delves deeper into the molecular basis of how cells work, how cells interact with their environment, basically the nuts and bolts of cells and their function.
Michael Way: Open Access publishing is very important for Journal of Cell Science because it enables people to get their research out to a wider, a more broad audience throughout the world. It means science can be disseminated faster and also you can show your wonderful science to your favourite relations who know nothing about science.They would be able to look it up as well.
Michael Way: The Company of Biologists is a not-for-profit publisher who aims to help the scientific community and Read & Publish deals are one of the new emerging models that are really helping the wider scientific community to actually spread their science and get the word out there.
Michael Way: The Read & Publish initiative is wonderful. It enables authors to publish multiple papers but pay no Open Access fees, as long as their institutes or universities are signed up for it.
Michael Way: So I think Read & Publish deals are the way forward and it helps everyone, it is a win-win situation.
Michael Way: I hope that more universities and institutes sign up to The Company of Biologists' Read & Publish initiative because this will allow their researchers to get their message out Open Access to the wider community.